Despite the augmented expression of SFRP5 in adipose tissues, it seems to decline following the aggravation of metabolic dysfunction, considering the transient upregulation of SFRP5 with milder inflammation in adipocytes and ensuing drop after the development of obesity. Here, SFRP5 is linked to Obesity.